$9.78
-0.71-6.82%
À la clôture: Nov 17, 4:00 PM EST

Generate Biomedicines (GENB) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
| Trimestre Fiscal | Date de Déclaration | BPA Réel | BPA Estimé | Surprendre % |
|---|---|---|---|---|
| Q3 | Nov 12, 2026 | $-0.68 | $-0.54 | -25.9 % |
| Q2 | Aug 6, 2026 | $-0.52 | $-0.49 | -6.12 % |
| Q1 | May 7, 2026 | $-1.07 | $-0.48 | -122.9 % |
Quarterly Revenue (Billions)
| Trimestre Fiscal | Date de Déclaration | Revenu Réel | Revenu Estimé | Surprendre % |
|---|---|---|---|---|
| Q3 | Nov 12, 2026 | $4.22M | $7.85M | -46.2 % |
| Q2 | Aug 6, 2026 | $6.31M | $5.52M | 14.3 % |
| Q1 | May 7, 2026 | $7.22M | $6.04M | 19.6 % |
| Metric | Q3 '26 | Q2 '26 | Q1 '26 |
|---|---|---|---|
| Earnings Per Share (Non-GAAP) | |||
| Estimate | $-0.54 | $-0.49 | $-0.48 |
| Actual | $-0.68 | $-0.52 | $-1.07 |
| Surprise | -25.9% | -6.12% | -122.9% |
| Revenue | |||
| Estimate | $7.8M | $5.5M | $6.0M |
| Actual | $4.2M | $6.3M | $7.2M |
| Surprise | -46.2% | +14.3% | +19.6% |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E | Q3 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.65 | $-0.60 | $-0.53 | $-0.52 |
| Revenue | ||||
| Consensus | $6.8M | $4.2M | — | — |